← Back to Patent Explorer
US4525355A Expired / Lapsed US ⏱️ 0.0 years remaining

7-β-Ureidoacetamido-oxacephalosporins

Assignee: Shionogi and Co Ltd
•
Filing: 1983-12-27
•
Granted: 1985-06-25
•
Expires: 2003-12-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A 7β-ureidoacetamido-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid derivative represented by the following formula: ##STR1## wherein Ar is phenyl, hydroxyphenyl, or thienyl and R is hydrogen, a light metal, or a carboxy-protecting group.

Inventors

  • 👤 Masayuki Narisada
  • 👤 Fumihiko Watanabe
  • 👤 Tetsuo Okada
  • 👤 Hiromu Matsumura

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 05:41
CPC Classifications
C; C07; C07D; C07D505/00; A; A61; A61P; A61P31/00; A61P31/04; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 28 words
A 7β-ureidoacetamido-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid derivative represented by the following formula: ##STR16## wherein Ar is phenyl, hydroxyphenyl, or thienyl and R is hydrogen, a light metal, or a carboxy-protecting group.
Claim 2
Dependent Claim 28 words
A 7β-ureidoacetamido-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid derivative represented by the following formula: ##STR16## wherein Ar is phenyl, hydroxyphenyl, or thienyl and R is hydrogen, a light metal, or a carboxy-protecting group.
Claim 3
Dependent Claim 13 words
A compound as claimed in claim 1 wherein Ar is phenyl or thienyl.
Claim 4
Dependent Claim 19 words
A compound as claimed in claim 1 wherein R is hydrogen, sodium, potassium, diphenylmethyl, p-methoxybenzyl, acetoxymethyl, 1-(ethoxycarbonyloxy)ethyl, or pivaloyloxymethyl.
Claim 5
Dependent Claim 18 words
Any one of the following compounds: 7β-[2-(2-thienyl)-2-ureidoacetamido]-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid, sodium 7β-[2-(2-thienyl)-2-ureidoacetamido]-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylate, pivaloyloxymethyl 7β-[2-(2-thienyl)-2-ureidoacetamido]-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylate, β -(2-phenyl-2-ureidoacetamido)-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid, and sodium 7β-(2-phenyl-2-ureidoacetamido)-7α-methoxy-3-(1-carboxylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylate.
Claim 6
Dependent Claim 18 words
Any one of the following compounds: 7β-[2-(2-thienyl)-2-ureidoacetamido]-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid, sodium 7β-[2-(2-thienyl)-2-ureidoacetamido]-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylate, pivaloyloxymethyl 7β-[2-(2-thienyl)-2-ureidoacetamido]-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylate, β -(2-phenyl-2-ureidoacetamido)-7α-methoxy-3-(1-carbamoylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid, and sodium 7β-(2-phenyl-2-ureidoacetamido)-7α-methoxy-3-(1-carboxylmethyl-1H-tetrazol-5-yl)thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylate.
Claim 7
Dependent Claim 14 words
A compound as claimed in claim 1 wherein the 7-side chain is in D-form.
Claim 8
Dependent Claim 18 words
An antibacterial composition comprising an effective amount of the compound as claimed in claim 1 and conventional carrier.
Claim 9
Dependent Claim 24 words
A method for combating bacteria which comprises bringing an effective amount of the compound as claimed in claim 1 to contact with the bacteria.

References Cited (Backward Citations)

US4232151A Cited
US4371532A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-06-24 1988-12-24 1989-06-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-06-24 1992-12-24 1993-06-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-06-24 1996-12-24 1997-06-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag